14-75039913-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001040108.2(MLH3):c.3568C>A(p.Gln1190Lys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000178 in 1,348,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001040108.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MLH3 | NM_001040108.2 | c.3568C>A | p.Gln1190Lys | missense_variant, splice_region_variant | 5/13 | ENST00000355774.7 | NP_001035197.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MLH3 | ENST00000355774.7 | c.3568C>A | p.Gln1190Lys | missense_variant, splice_region_variant | 5/13 | 5 | NM_001040108.2 | ENSP00000348020 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000362 AC: 5AN: 138056Hom.: 0 Cov.: 26
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248514Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134546
GnomAD4 exome AF: 0.0000157 AC: 19AN: 1210874Hom.: 0 Cov.: 17 AF XY: 0.0000261 AC XY: 16AN XY: 612354
GnomAD4 genome AF: 0.0000362 AC: 5AN: 138056Hom.: 0 Cov.: 26 AF XY: 0.0000606 AC XY: 4AN XY: 66030
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The p.Q1190K variant (also known as c.3568C>A), located in coding exon 4 of the MLH3 gene, results from a C to A substitution at nucleotide position 3568. The glutamine at codon 1190 is replaced by lysine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Colorectal cancer, hereditary nonpolyposis, type 7 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 410887). This variant has not been reported in the literature in individuals affected with MLH3-related conditions. This variant is present in population databases (rs779651509, gnomAD 0.01%). This sequence change replaces glutamine, which is neutral and polar, with lysine, which is basic and polar, at codon 1190 of the MLH3 protein (p.Gln1190Lys). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at